Blue Jay Capital Management’s Labcorp LH Stock Holding History

Blue Jay Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-98,940	Closed	-$10.9M	–	24
2016 Q4	$10.9M	Buy	+98,940	New	+$11M	6.58%	9

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Blue Jay Capital Management's LH Position: Q1 2017 in Review

Blue Jay Capital Management sold out of Labcorp (LH) in Q1 2017, closing a stake of 98,940 shares — an estimated $10.9M sold.

Blue Jay Capital Management first reported a position in LH in Q4 2016 and held it in 1 quarter. The position peaked at $10.9M in Q4 2016. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

Blue Jay Capital Management reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
Blue Jay Capital Management sold 98,940 Labcorp shares in Q1 2017, an estimated $10.9M.
Blue Jay Capital Management first reported a position in Labcorp in Q4 2016 and held it in 1 quarter.
Blue Jay Capital Management's Labcorp position peaked at $10.9M in Q4 2016.
693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on Blue Jay Capital Management's 13F filing for Q1 2017, filed 12 May 2017.